- Previous Close
60.80 - Open
60.10 - Bid 59.90 x 13800
- Ask 60.70 x 13700
- Day's Range
59.30 - 60.10 - 52 Week Range
42.70 - 68.60 - Volume
70 - Avg. Volume
108 - Market Cap (intraday)
1.01B - Beta (5Y Monthly) 0.28
- PE Ratio (TTM)
9.00 - EPS (TTM)
6.61 - Earnings Date Apr 30, 2025
- Forward Dividend & Yield 2.03 (3.41%)
- Ex-Dividend Date May 12, 2025
- 1y Target Est
72.60
Drägerwerk AG & Co. KGaA operates as a medical and safety technology company worldwide. It develops, produces, and markets system solutions, devices, and services for the medical division, including emergency medicine, perioperative care, intensive care, and perinatal medicine. The company also develops, produces, and markets products, system solutions, and services for personal protection, gas measurement technology, and comprehensive risk management to customers in industry and mining sectors, as well as public sectors, such as fire departments, police, and disaster protection. Its products include patient monitoring systems; anaesthesia machines; medical ventilators and lung monitoring; neonatal incubators and thermoregulation; phototherapy lights and bilirubinometers; surgical and examination lights; medical pendants and infrastructure design; medical gas pipeline system in hospitals; and hospital consumables and accessories, as well as hospital planning and design services. In addition, the company offers alcohol and drug testing; fixed gas detectors; hazmat suits; portable gas detection; head protection; rescue and escape; respiratory protection; safety-training systems; thermal imaging cameras; and workshop solution and breathing gas supply. Further, it provides various training and services. The company was founded in 1889 and is headquartered in Lübeck, Germany. Drägerwerk AG & Co. KGaA operates as a subsidiary of Stefan DrÄGer Gmbh.
www.draeger.comRecent News: DRW3.F
View MorePerformance Overview: DRW3.F
Trailing total returns as of 4/17/2025, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: DRW3.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: DRW3.F
View MoreValuation Measures
Market Cap
1.01B
Enterprise Value
1.16B
Trailing P/E
9.00
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.33
Price/Book (mrq)
0.73
Enterprise Value/Revenue
0.34
Enterprise Value/EBITDA
5.72
Financial Highlights
Profitability and Income Statement
Profit Margin
3.69%
Return on Assets (ttm)
3.32%
Return on Equity (ttm)
8.47%
Revenue (ttm)
3.37B
Net Income Avi to Common (ttm)
124.41M
Diluted EPS (ttm)
6.61
Balance Sheet and Cash Flow
Total Cash (mrq)
230.6M
Total Debt/Equity (mrq)
25.74%
Levered Free Cash Flow (ttm)
84.63M